Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cronos Group Inc (CRON) vs T-Mobile Us Inc (TMUS) Price & Performance

Cronos Group IncTrade
T-Mobile Us IncTrade

Price performance (Past 24H)

Key statistics

Cronos Group Inc vs T-Mobile Us Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while T-Mobile Us Inc trades at $148.58 (market cap $183.76B). The key difference: T-Mobile Us Inc is far larger — about 155.7× Cronos Group Inc's market cap, and T-Mobile Us Inc pays a 2.73% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and T-Mobile Us Inc for 84 Days on average.

CRONTMUS
Market Cap
$1.18B$183.76B
Volume
968,0374,294,650
Sector
HealthMedia
52-Week High
$3.55$230.06
52-Week Low
$2.30$148.58
Typical Hold Time
22 Days84 Days
Enterprise Value
$387.62M$300.37B
Dividend Yield
—2.73%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cronos Group Inc

CRON trades at $3.22, down 0.62% on the day, with a bearish technical signal from moving averages. The company reported strong Q2 2026 results, beating earnings estimates with 58% YoY revenue growth, and maintains a robust balance sheet with $827 million in cash and no debt. Recent investor day highlighted expansion in Canada and international markets.

Outlook is mixed; profitability improved with net income margin turning positive in 2026 forecasts, but high EV/EBITDA of 43 suggests premium valuation. Risks include execution of growth plans and cannabis sector volatility. Analyst consensus is cautious with 60% hold ratings.

T-Mobile Us Inc

TMUS trades at $171.31, up 2.2% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $88.31B in 2025, with a net income margin of 11.45%, while the company announced a 15% dividend hike and AI-driven 5G network enhancements. Analyst consensus is strongly bullish with a $231.10 price target, though debt levels and competitive pressures remain considerations.

The outlook for TMUS is positive, driven by robust cash flow, strategic investments in network resilience, and favorable analyst sentiment. Key risks include high debt exposure and industry competition, but strong fundamentals and growth initiatives support a constructive view for long-term investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CRON

No sentiment data available yet.

TMUS
53% Buy47% Sell
Avg holding period · 84 Days

Top news

Latest headlines on both assets

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON →

About T-Mobile Us Inc

Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, creating T-Mobile Us. Following the merger, the firm provided nationwide service in major markets but spottier coverage elsewhere. T-Mobile spent aggressively on low-frequency spectrum, well suited to broad coverage, and has substantially expanded its geographic footprint. This expansion, coupled with aggressive marketing and innovative offerings, produced rapid customer growth. With the Sprint acquisition, the firm's scale now roughly matches its larger rivals: T-Mobile now serves 71 million postpaid and 21 million prepaid phone customers, equal to around 30% of the U.S. retail wireless market. In addition, the firm provides wholesale service to resellers.

Read more on TMUS →